Skip to main content

Snow Jessica's Form 4/A amendment

Amended

2seventy bio, Inc. (TSVT) · filed Jan 22, 2025

Accession no.
0001562180-25-000457
Filed
Jan 22, 2025
Trade date
Jan 6, 2025
Filing delay
16 days
Rule 10b5-1 plan
Checked
Original filed
Jan 7, 2025

This filing lists 1 non-derivative transaction. It carries over 3 transactions from the original filing that it did not restate. Open-market sales total $22.5K. It was filed 16 days after the trade.

This amendment restates part of 0001562180-25-000246 (filed Jan 7, 2025). The transactions it did not restate still count and are listed below.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Snow JessicaCIK 0002009134Officer (See Remarks)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 6, 2025Common StockSSaleDisposed−1,838$2.79−$5,128.02150,527Direct

Carried over from the original filing

This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.

From 0001562180-25-000246 (filed Jan 7, 2025).

Non-derivative securities (Table I)

Non-derivative transactions carried over from 0001562180-25-000246
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 3, 2025Common StockSSaleDisposed−1,000$2.94F2−$2,940152,479Direct
Jan 6, 2025Common StockSSaleDisposed−5,000$2.79F5−$13,950147,365Direct
Jan 7, 2025Common StockSSaleDisposed−186$2.64−$491.04147,179Direct

Footnotes on the original

The footnotes that the prices of these transactions refer to on the original filing.

F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.87 to $3.01, inclusive. The Reporting Person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F5

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.63 to $2.95, inclusive. The Reporting Person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

On January 7, 2025, the Reporting Person filed a Form 4 which inadvertently reported the incorrect number of shares sold on January 6, 2025 pursuant to a Rule 10b5-1 trading plan (the "Original Form 4"). The Original Form 4 reported a sale of 5,000 shares and this Form 4 amendment is being filed to report the correct number of shares sold as 1,838.

Remarks

Title: Senior Vice President of Quality and Enabling Functions

Read the full filing on SEC EDGAR (opens in a new tab)